Granulocyte-macrophage colony-stimulating factor (GM-CSF) and the related cytokines interleukin (IL)-3 and IL-5 regulate the production and functional activation of hematopoietic cells. GM-CSF acts on monocytes/macrophages and granulocytes, and several chronic inflammatory diseases and a number of haematological malignancies such as Juvenile myelomonocytic leukaemia (JMML) are associated with deregulated GM-CSF receptor (GMR) signaling. The downregulation of GMR downstream signaling is mediated in part by the clearance of activated GMR via the proteasome, which is dependent on the ubiquitylation of bc signaling subunit of GMR via an unknown E3 ubiquitin ligase. Here, we show that suppressor of cytokine signaling 1 (SOCS-1), best known for its ability to promote ubiquitin-mediated degradation of the non-receptor tyrosine kinase Janus kinase 2 (JAK2), also targets GMRbc for ubiquitin-mediated degradation and attenuates GM-CSF-induced downstream signaling.
Introduction
GM-CSF and the related cytokines IL-3 and IL-5 regulate haematopoietic cell survival, proliferation, differentiation, migration, and perform effector functions such as phagocytosis or reactive oxygen species release [1] . Unlike other cytokine receptors, GMR has a significant nonredundant role in macrophage-mediated acute and chronic inflammation, pulmonary homeostasis, allergic diseases, and myeloid haematologic malignancies [2] . For example, juvenile myelomonocytic leukaemia (JMML) is an aggressive myeloproliferative neoplasm in children characterized by the over-production of monocytic cells that infiltrate the spleen, lung and liver [3, 4] . A hallmark feature of JMML is acquired hypersensitivity by clonal myeloid progenitor cells to GM-CSF. We recently demonstrated that the hypersensitivity of JMML cells harboring the most prevalent JMMLcausing Cbl mutation, Y371H, to GM-CSF is due to the defective E3 ligase function of mutant Cbl(Y371H) towards Src family kinases that in turn hyper-phosphorylate and activate GMR to promote GMR hypersensitivity [5] .
GMR is composed of a ligand-specific a chain (GMRa) and a b common (bc) signaling subunit, which is shared with the IL-3 and IL-5 receptors [6] . Upon binding of GM-CSF to GMRa, a higherorder signaling complex is formed that promotes the activation of non-receptor tyrosine kinases JAK2 and Src family kinases (Src and Lyn), which subsequently phosphorylate GMRbc [7] . Activated GMR serves as a docking site for adaptors and signaling molecules resulting in activation of downstream signaling [7] . While the molecular mechanisms underlying GMR activation have been extensively studied [2] , negative regulation of GMR signaling has been less explored. Martinez-Moczgyzemba and colleagues previously showed that the cytoplasmic domain of bc is ubiquitylated and degraded by the proteasome in response to stimulation by GM-CSF, IL-5 and IL-3 [8] [9] [10] ; however, the ubiquitin ligase that targets bc for ubiquitin-mediated degradation remains unknown. Here, we identify suppressor of cytokine signaling 1 (SOCS-1) as an E3 ligase that binds to and ubiquitylates bc to promote its degradation via the 26S proteasome and attenuates GMR downstream signaling.
Materials and Methods

Cells
HEK293 and TF-1 cells were obtained from the American Type Culture Collection. HEK293 cells were maintained in Dulbecco's Modified Eagle's Medium (DMEM; Wisent, St-Bruno, QC, Canada) supplemented with 10% heat-inactivated fetal bovine serum (FBS; Wisent, St-Bruno, QC, Canada) at 37uC in a humidified 5% CO2 atmosphere. TF-1 cells were maintained similarly in RPMI-1640 (Wisent, St-Bruno, QC, Canada) medium supplemented with 10% FBS and 2 ng/ml GM-CSF (Invitrogen, Burlington, ON, Canada). Stable knockdown of Cbl in TF-1 cells was generated as previously described [5] .
Antibodies
Antibodies against EPOR, GMRa, GMRbc (monoclonal and polyclonal), pERK, were obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Monoclonal antibodies against HA (12CA5), STAT5 and ubiquitin were obtained from Boehringer Ingelheim (Ridgefield, CT, USA), Millipore (Billerica, MA, USA), and Dako (Burlington, ON, Canada), respectively. Polyclonal antibodies against FLAG and SOCS-1 were purchased from Novus Biologicals (Oakville, ON, Canada). JAK2, pJAK2 and pSTAT5 antibodies were purchased from Cell Signaling Technology (Danvers, MA, USA). Monoclonal FLAG, b-actin and total ERK antibodies were obtained from Sigma (Oakville, ON, Canada).
Plasmids
pSG5-GMRa and pSG5-GMRbc constructs were generously provided by Dr. Timothy R. Hercus. HA-ubiquitin plasmid was a gift from Dr. Zhijian Chen. Plasmids encoding Flag-SOCS-1, -2 and -3, SOCS-1nSOCSBox have been previously described [11] . The triple lysine K.R mutant of bc, (K457R, K461R, K467R) [10] was generated using the QuikChange Site-Directed Mutagenesis Kit from Invitrogen (Burlington, ON, Canada) and the following primer pair: 59-CTGCGCAGAAGGTGGGAGGA-GAGGATCCCCAACCCCAGCAGGAGC CACCTG, 59-CAGGTGGCTCCTGCTGGGGTTGGG-GATCCTCTCCTCCCACCTTCTGCGCAG. The presence of the indicated substitution mutations was confirmed by direct DNA sequencing.
Immunoprecipitation and immunoblotting
Immunoprecipitation and Western blotting were performed as described previously [12] . In brief, cells were lysed in EBC buffer 
SOCS-1 knockdown via lentivirus-shRNA
The following pGIPZ plasmids from Thermo Scientific (Billerica, MA, USA) were used to generate lentivirus for indicated shRNA-mediated knockdown: RHS4346 non-silencing control and V2LHS_23983 human SOCS1 shRNA. TF-1-shSOCS-1 and TF-1-shScr cells were generated by infection with lentivirus and selection in puromycin. The knockdown of SOCS-1 was confirmed by Western blot analysis and real-time quantitative PCR (qPCR).
RNA purification and real-time qPCR
Total RNA was extracted using the Qiagen RNeasy extraction kit (Qiagen, Hilden, Germany) as per the provided protocol. cDNA was synthesized using random hexamer primer Thermo Scientific (Billerica, MA, USA), 5X First-Strand Buffer, 0.1 M DTT, 100 mM dNTP set, and SuperScript II Reverse Transcriptase (Invitrogen). qPCR was performed using the CFX384 RealTime PCR Detection System from Bio-Rad, (Mississauga, Ontario, Canada) and expression levels were determined with the Bio-Rad CFX Manager 3.0 software Bio-Rad (Mississauga, Ontario, Canada). Each qPCR reaction totaled 10 uL and consisted of 1:4 diluted cDNA, 400 nM of each primer, and 2x SYBR Green Supermix Bio-Rad (Mississauga, Ontario, Canada). Amplification conditions were as follows: 95uC (3 min); 40 cycles of 95uC (10 s), 55uC (30 s); 65uC (5 s). Values were normalized to b-Actin mRNA and expressed relative to shScr samples (arbitrarily 
Statistical analyses
Unpaired two-tailed Student t test was used to compare between treatment groups and cell types. All statistical analysis was performed using GraphPad PRISM 5.0 software (La Jolla, CA, USA). Statistical significance was achieved at the confidence limit indicated.
Results
We and others identified sporadic and germline CBL mutations in 10-15% of JMML patients with Y371H mutation emerging as the most common mutation that resulted in the loss of Cbl's ubiquitin ligase function [5, 13, 14] . Intriguingly, while mutations in Cbl abrogated the ubiquitin-mediated negative regulation of GMR-associated Src kinase turnover [5] , the level of GMR remained unchanged (Fig. S1) , which suggests that in the context of GM-CSF-induced signaling, Cbl is not the E3 responsible for the purported ubiquitin-mediated degradation of bc.
Suppressor of cytokine signaling (SOCS) proteins are negative regulators of cytokine receptor signaling [15] , and SOCS-1 is the substrate-conferring component of an E3 ubiquitin ligase that has been shown to target JAK2 for ubiquitin-mediated destruction [16, 17] . Considering that E3 ligases often have multiple targets and the physical association, and therefore the close proximity, of GMRbc to JAK2, we asked whether SOCS-1 ubiquitylates GMRbc. Ectopic Flag-SOCS-1 expression in HEK293 cells attenuated the expression level of endogenous JAK2 as expected and also marked decreased the level of ectopic GMRa and GMRbc (Fig. 1a) . However, Flag-SOCS-1 had negligible influence on the expression level of another cytokine receptor, erythropoietin receptor (EPOR), known to associate with and signal via JAK2 (Fig. 1a) . GM-CSF-induced GMRbc degradation was also dramatically increased in cells co-expressing Flag-SOCS-1 and GMRa/bc in comparison to cells ectopically expressing GMRa/bc alone (Fig. 1b) . Furthermore, proteasomal inhibitor MG132 treatment increased the steady state level of GMRbc and importantly, blocked SOCS-1-dependent attenuation of GMRbc level (Fig. 1c) . These results suggest that SOCS-1 promotes proteasome-dependent turnover of GMRbc.
We next asked whether SOCS-1 associates with GMRbc. Flag-SOCS-1 preferentially co-precipitated with GMRbc whereas GMRbc co-precipitated minimal or negligible levels of the closely related family members SOCS-2 or SOCS-3 ( Fig. 2a and b) . In addition, SOCS-1, but not SOCS-3, promoted GMRbc ubiquitylation, which was visualized upon treatment with MG132 (Fig. 2b) . The SOCS-box domain within SOCS-1 is required to recruit elongins B/C and Cul5 or Cul2 to form an E3 ubiquitin ligase complex and is indispensable for mediating the ubiquitylation of target proteins [18] . The SOCS-box deletion mutant of SOCS-1, while retaining modest binding to GMRbc, increased the total level of GMRbc, which was most noticeable in the absence of MG132 (Fig. 2c) . These results suggest that SOCS-1 binds to and ubiquitylates GMRbc.
Covalent modification of target proteins with ubiquitin occurs almost invariably on lysine residues. Previous studies have identified a cluster of three membrane-proximal GMRbc lysine residues (K457, K461 and K467) required for receptor-mediated ubiquitylation [10] . SOCS-1 mediated GMRbc ubiquitylation, which is stabilized and visualized in the presence of MG132, was markedly attenuated in GMRbc(3K.R) substitution mutant (Fig. 3) . These results suggest that ectopic SOCS-1 promotes GMRbc ubiquitylation on one or more of these three lysine residues.
The human myeloid leukemia cell line TF-1 expresses endogenous SOCS-1 and GMR, and is dependent on GM-CSF for growth and survival. GM-CSF engagement of GMRa initiates rapid GMRbc recruitment and the activation of downstream signaling, which is subsequently followed by an equally rapid downregulation of GMR signaling. Upon GM-CSF stimulation of TF-1 cells, GMRbc co-precipitated with endogenous SOCS-1; the interaction of which was associated with increased GMRbc ubiquitylation (Fig. 4a) . Moreover, the extent of GMRbc ubiquitylation and interaction with SOCS-1 diminished markedly following the initial induction upon GM-CSF treatment (Fig. 4a) . Knockdown of endogenous SOCS-1 using lentivirus-driven shRNA against SOCS-1 in comparison to scrambled lenti-shRNA (shScr) in TF-1 cells increased the level of GMRbc (Fig. 4b and   Fig. S2 ). The knockdown of SOCS-1 also attenuated GMRbc ubiquitylation as visualized in the presence of MG132 following GMRbc immunoprecipitation under non-saturating anti-GMRbc antibody concentration to approximate equal loading of GMRbc in the Western blot analysis (Fig. 4c) . Moreover, GM-CSFdependent signaling was concordantly enhanced in TF-1-ShSOCS-1 cells compared to TF-1-ShScr cells as noted by increased level and duration of phosphorylated STAT5 or ERK (Fig. 4d) . These results support the notion that SOCS-1 promotes ubiquitin-mediated degradation of GMRbc and the negative regulation of GMR signaling.
Discussion
The binding of GM-CSF to the ligand specific GMRa promotes the formation of a higher-order signaling complex that leads to the activation of non-receptor tyrosine kinases JAK2 and Src family kinases (c-Src and Lyn), which subsequently phosphorylate GMRbc to initiate downstream signaling [7] . SOCS-1 has been shown to negatively regulate JAK2 and consequently GM-CSF signaling by inhibiting phosphorylation [19] as well as promoting ubiquitin-mediated proteasome-dependent degradation [16] of JAK2. Here, we show that SOCS-1 also ubiquitylates GMRbc for subsequent destruction via the proteasome.
EPO-mediated signaling induces the expression of SOCS-1 [20] , which is required for ubiquitin-mediated destruction of JAK2 and the suppression of EPOR downstream signaling. However, unlike GMRbc, SOCS-1 did not negatively regulate the expression level of EPOR. This is consistent with previous findings showing that JAK2-mediated degradation of EPOR is dependent on another E3 ligase containing the F-box protein b-TrCP [21] , [22] and that progenitor cells from SOCS-1 2/2 mice are hypersensitive towards GM-CSF but not to other cytokines such as M-CSF or G-CSF [23, 24] . It is at present unclear why the recruitment of SOCS-1 to certain activated cytokine receptors leads to the degradation of only JAK2 via SOCS-1 while the receptor itself is targeted by another E3 ubiquitin ligase, such as in the case for the EPOR, whereas SOCS-1 recruitment to activated GMR results in the degradation of both JAK2 and GMRbc via SOCS-1. One of many possibilities is that in the case of EPOR, the duration of other downstream signaling events are likely temporally distinct from JAK2-STAT signaling; thus, there would be distinct and separate negative regulatory processes that regulate multiple downstream signaling events emanating from EPOR. In the case of GMR, it is possible that the downstream signaling pathways are regulated at similar temporal points post receptor activation. In addition, bc is shared among IL-3, IL-5 and GM-CSF receptors and hence, it may be more efficient to have one E3 ligase, namely SOCS-1-containing E3 ligase, which is responsible for the degradation of the receptor-kinase complex upon specific ligand-induced activation. These notions and whether JAK2 plays a role in SOCS-1-mediated ubiquitylation of GMRbc remain as outstanding questions. 
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